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Breast cancer is the main cause of cancer death in women 
worldwide. It is a heterogeneous cancer, with different subtypes 
and associated therapies and prognosis. We investigated the well 
adopted (expression based) PAM50 tumor classification and tried 
to assess pathway activity for each subtype. We developed a new 
network based method that integrates, in a single step, different 
types of data and prior knowledge in the form of known gene 
interactions. Using the method, 210 KEGG pathways were given a 
score that expresses the affinity of the pathway with each of the 
PAM50 subtypes. Our results recapitulate to a large extent what is 
known about pathway activity in breast cancer, confirming the 
potential of the proposed method to select relevant pathways 
from a number of candidate pathways. 
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We used data from The Cancer Genome Atlas (TCGA). Data were 
downloaded for 463 patients with a known PAM50 based subtype. The 
following data types were available (Figure 1): 
 Gene expression (1700 differentially expressed genes selected)  
 Somatic mutations (522 mutations selected using an external 
procedure) 
 Copy number variation (tumor vs. normal, 141 genes selected) 
 210 KEGG pathways (disease pathways were not included) 
The data 
All data were integrated in a single dataset using a network based 
approach (Figure 2). The integrated network contains different types 
of entities as nodes: 
 Patients 
 Genes 
 Mutations 
 Copy number aberrations 
These entities are connected using different types of relations. We 
incorporated prior knowledge in the form of known gene – gene 
interactions.  
Once the integrated network is constructed, network based similarity 
measures can be used to calculate the average similarity between a 
group of patients and the genes in a particular pathway. These 
similarities can then be converted to an affinity score (between 0 – no 
affinity and 1 – very high affinity) representing the importance of each 
pathway for a given breast cancer subtype. We expect the best 
scoring pathways to be involved in signaling, cell cycle and apoptosis. 
Method 
We calculated a similarity score for each subtype vs. each of 210 
KEGG pathways, and ranked the pathways according to their average 
similarity score over all subtypes (Basal, Her2, Luminal A and Luminal 
B).  
Figure 3 displays the top 30 best scoring pathways, together with an 
indication how variable the score was between subtypes. Our results 
are in line with the results of PARADIGM (Vaske et al. ,2010, 
Bioinformatics 26).  
Some interesting pathways were cherry-picked and displayed in 
relation to all available data in more detail in Figure 4.  
Results Gen
e
 e
x
p
re
s
s
io
n
 
M
u
ta
tio
n
s
 
C
N
V
 
G
e
n
e
 e
x
p
re
s
s
io
n
 
M
u
ta
tio
n
s
 
C
N
V
 
Figure 4. Two interesting high-scoring pathways illustrating differences 
between breast cancer subtypes (red=high expression, mutated or copy 
number amplification, green=low expression or copy number deletion) 
Figure 3. The top 30 best-scoring KEGG 
pathways 
Figure 1. overview and interrelation of the 
different data sources 
Figure 2. The integrated network 
containing different types of entities and 
relations 
